Scisparc

Scisparc Share Buybacks

Share Buybacks of Scisparc (SPRC) as of Oct 15, 2026.

Share Buybacks

-USD

Last updated:

Share Buybacks of Scisparc is 2026 - USD. Share Buybacks of Scisparc was 2025 6.00 M USD. It decreases by % lower compared to the previous year.

The Scisparc Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2017
13.00 M USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
2.00 M USD
Jan 1, 2020
5.00 M USD
Jan 1, 2021
10.00 M USD
Jan 1, 2022
11.00 M USD
Jan 1, 2023
5.00 M USD
Jan 1, 2024
6.00 M USD
The Scisparc Share Buybacks history
YEARShare BuybacksYoY
6.00 MUSD+20.00%
5.00 MUSD-54.55%
11.00 MUSD+10.00%
10.00 MUSD+100.00%
5.00 MUSD+150.00%
2.00 MUSD—
0.00USD-100.00%
13.00 MUSD—
0.00USD-100.00%
2.00 MUSD—
0.00USD-100.00%
2.00 MUSD—
0.00USD-100.00%
1.00 MUSD0.00%
1.00 MUSD—
0.00USD—
0.00USD-100.00%
5.00 MUSD—
0.00USD-100.00%
7.00 MUSD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Scisparc Stock analysis

What does Scisparc do? Scisparc Ltd., listed under the ticker SPRC with ISIN IL0010951403, is a biotechnology company headquartered in Tel Aviv-Yafo, Israel. The company operates in the healthcare sector and has a workforce of three employees. Scisparc Ltd. went public through an IPO on December 22, 2021. Its website is https://scisparc.com/. The company is engaged in the development of pharmaceutical products based on cannabinoid technologies, focusing on repurposing dronabinol for various medical conditions. Specific drug development programs include THX-110 for Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for infectious diseases; and THX-160 for pain treatment. Scisparc Ltd. is a clinical stage pharmaceutical company, indicating its focus on advancing drug candidates through clinical trials toward potential regulatory approval and commercialization. The company's activities are centered around leveraging cannabinoid-based approaches to address unmet medical needs in multiple therapeutic areas. Scisparc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Scisparc stock

On Eulerpool you can find the complete historical development of Share Buybacks Scisparc since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Scisparc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Scisparc

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Scisparc